Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Objectives: Previous studies have suggested that women with bipolar disorder are at higher risk for mood episodes during periods of intense hormonal fluctuation (e.g., premenstrual, postpartum, perimenopause). There is converging literature showing that estrogen and progesterone can modulate neurotransmitter systems and intracellular signaling pathways known to be affected by mood stabilizing agents. Here, we critically review clinical aspects of reproductive cycle events in women with bipolar disorder and preclinical studies, with a focus on the functional interactions between sex hormones and biomarkers of neuroprotection and neurodegeneration that are thought to be involved in the neurobiology of bipolar disorder: brain‐derived neurotrophic factor, oxidative stress, and inflammation. Methods: A MedLine search using estrogen,progesterone,brain‐derived neurotrophic factor,oxidative stress, and inflammation as key words was conducted. Results: Data showed that estrogen and progesterone closely interact with brain‐derived neurotrophic factor, oxidative stress, and inflammation pathways. Conclusions: This relationship between sex hormones and the pathways of neuroprotection/neurodegeneration may be relevant to the psychopathological aspects of bipolar disorder in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neural mechanisms of ageing and cognitive decline
Bishop, N. A., Lu, T., & Yankner, B. A. (2010) · Nature · doi:10.1038/nature08983 · Cited by 1,323 · cited 1×
“Oxidative damage to lipids and proteins due to excessive generation of reactive oxygen species (ROS) and/or a decrease in enzymatic and non-enzymatic defenses (oxidative stress) are key processes in neurodegenerative disorders and cognitive decline associated with aging (64).”
BackgroundEffects of gonadal steroids in women with a history of postpartum depression
Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.924 · Cited by 950
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Estrogen Actions in the Central Nervous System
McEwen, B. S. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.279 · Cited by 640
Viguera, A. C., Whitfield, T., Baldessarini, R. J., Newport, D. J., Stowe, Z., Reminick, A., Zurick, A., & Cohen, L. S. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101639 · Cited by 599 · cited 2×
“In this study, the episodes were more likely to occur in the first trimester and were more likely to be depressive or mixed (17).”
BackgroundPrevalence, incidence and stability of premenstrual dysphoric disorder in the community
WITTCHEN, H.-U., BECKER, E., LIEB, R., & KRAUSE, P. (2002) · Psychological Medicine · doi:10.1017/s0033291701004925 · Cited by 554
Oxidative stress markers in bipolar disorder: A meta-analysis
Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526
Self-citationAndreazza, A. C., Shao, L., Wang, J.-F., & Young, L. T. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.22 · Cited by 448
Rao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Fernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389
Bernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372
Zeidan, M. A., Igoe, S. A., Linnman, C., Vitalo, A., Levine, J. B., Klibanski, A., Goldstein, J. M., & Milad, M. R. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.016 · Cited by 354 · cited 1×
“For instance, estrogen and progesterone can modulate sleep and circadian rhythms (119, 120), anxiety/fear extinction (121), as well as processes of learning and memory (6).”
BackgroundEstrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels
Stirone, C., Duckles, S. P., Krause, D. N., & Procaccio, V. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014662 · Cited by 315
Risks and predictors of readmission for a mental disorder during the postpartum period
Munk-Olsen, T., Laursen, T. M., Mendelson, T., Pedersen, C. B., Mors, O., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.528 · Cited by 299 · cited 1×
“In fact, diagnosis of BD is the best predictor for psychiatric readmission within the first three weeks postpartum (22).”
BackgroundProgesterone and Estrogen Regulate Oxidative Metabolism in Brain Mitochondria
Irwin, R. W., Yao, J., Hamilton, R. T., Cadenas, E., Brinton, R. D., & Nilsen, J. (2008) · Endocrinology · doi:10.1210/en.2007-1227 · Cited by 289
Frey, B. N., Andreazza, A. C., Houenou, J., Jamain, S., Goldstein, B. I., Frye, M. A., Leboyer, M., Berk, M., Malhi, G. S., Lopez-Jaramillo, C., et al. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413478217 · Cited by 234
Self-citationYildiz, A., Guleryuz, S., Ankerst, D. P., Öngür, D., & Renshaw, P. F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.43 · Cited by 213 · cited 1×
“In this context, two small randomized controlled trials have revealed robust anti-manic effects with the ER- and protein kinase C (PKC) antagonist, tamoxifen (112, 113).”
BackgroundMorale, M. C., Serra, P. A., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Gennuso, F., Giaquinta, G., Rocchitta, G., Desole, M. S., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.060 · Cited by 207
Dunham, J. S., Deakin, J. F. W., Miyajima, F., Payton, A., & Toro, C. T. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.03.008 · Cited by 172
Yang, L.-C., Zhang, Q.-G., Zhou, C.-F., Yang, F., Zhang, Y.-D., Wang, R.-M., & Brann, D. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009851 · Cited by 163
Mitochondrial Effects of Estrogen Are Mediated by Estrogen Receptor α in Brain Endothelial Cells
Razmara, A., Sunday, L., Stirone, C., Wang, X. B., Krause, D. N., Duckles, S. P., & Procaccio, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134072 · Cited by 161
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
Che, Y., Wang, J.-F., Shao, L., & Young, L. T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090083 · Cited by 155
Joffe, H., Cohen, L. S., Suppes, T., McLaughlin, W. L., Lavori, P., Adams, J. M., Hwang, C. H., Hall, J. E., & Sachs, G. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.017 · Cited by 134
Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder
GALLAGHER, P., WATSON, S., SMITH, M., YOUNG, A., & FERRIER, I. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.020 · Cited by 129 · cited 1×
“Plasma DHEA levels in BD patients were found to be higher when compared with controls and lower when compared with subjects with schizophrenia (125).”
ResultCytokine levels in euthymic bipolar patients
Guloksuz, S., Aktas Cetin, E., Cetin, T., Deniz, G., Oral, E. T., & Nutt, D. J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.027 · Cited by 102
Hardoy, M. C., Serra, M., Carta, M. G., Contu, P., Pisu, M. G., & Biggio, G. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000229483.52955.ec · Cited by 80 · cited 1×
“, allopregnanolone) in mood and behavior (134, 135).”
BackgroundPregnancy and Bipolar Disorder: A Systematic Review
Sharma, V., & Pope, C. J. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07499 · Cited by 75
Dias, R. S., Lafer, B., Russo, C., Del Debbio, A., Nierenberg, A. A., Sachs, G. S., & Joffe, H. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09121816 · Cited by 70 · cited 3×
“(2) found that women with BD who reported premenstrual exacerbation of mood symptoms (depression or mood swings) had more depressive episodes and relapsed earlier than women with BD with no premenstrual exacerbation.”
BackgroundMethodSelf-citationMarsh, W. K., Templeton, A., Ketter, T. A., & Rasgon, N. L. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.12.006 · Cited by 48 · cited 3×
“Although it has long been recognized that the postpartum is a period of higher risk of relapse in BD, recent data suggest that the premenstrual phase and menopausal transition are also associated with an elevated risk of a mood episode (2, 3, 16).”
BackgroundMethodRobertson Blackmore, E., Craddock, N., Walters, J., & Jones, I. (2008) · Archives of Women's Mental Health · doi:10.1007/s00737-008-0215-2 · Cited by 34
Comorbid bipolar disorder and premenstrual dysphoric disorder: real patients, unanswered questions
Frey, B. N., & Minuzzi, L. (2013) · Archives of Women's Mental Health · doi:10.1007/s00737-012-0313-z · Cited by 22
Self-citation
Cited by
Slyepchenko, A., Frey, B. N., Lafer, B., Nierenberg, A. A., Sachs, G. S., & Dias, R. S. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12797 · Cited by 49
“Notably, several independent studies found an association between premenstrual, postnatal, and perimenopausal worsening of symptoms in women with BD (12–14), suggesting that a subset of women with BD is particularly vulnerable during periods of hormonal fluctuation (15).”
BackgroundSelf-citationHaimov-Kochman, R., & Berger, I. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00191 · Cited by 40
“Thus, it is conceivable to believe that this functional interaction between sex hormones and molecules involved with synaptic plasticity and neurotransmitter systems may be associated with some of the clinical characteristics of women with ADHD (Frey and Dias, 2014).”
BackgroundFemale-specific pharmacotherapy in ADHD: Premenstrual adjustment of psychostimulant dosage
de Jong, M., Wynchank, D. S. M. R., van Andel, E., Beekman, A. T. F., & Kooij, J. J. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1306194 · Cited by 39
Hatch, J., Andreazza, A., Olowoyeye, O., Rezin, G. T., Moody, A., & Goldstein, B. I. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.04.005 · Cited by 39
The relationship between inflammatory state and quantity of affective episodes in bipolar disorder
Queissner, R., Pilz, R., Dalkner, N., Birner, A., Bengesser, S. A., Platzer, M., Fellendorf, F. T., Kainzbauer, N., Herzog-Eberhard, S., Hamm, C., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.024 · Cited by 35
Metadata
- Authors
- Frey, B. N., & Dias, R. S.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2013-11-11
- Volume
- 16
- Issue
- 1
- Pages
- 48-57
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W2081459415
- Cited by
- 73
- References
- 33
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.